| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | United States | 4 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Australia | 2 | |
| #5 | Canada | 2 | |
| #6 | China | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Microorganisms | |
| #5 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Shahar Michal | 10 |
| #2 | Yamamoto Nobuto | 7 |
| #3 | Margalit Ilana | 7 |
| #4 | Spitzer Aya | 6 |
| #5 | Lifshits Sveta | 6 |
| #6 | Yogev Uri | 5 |
| #7 | Rotem-Yehudar Rinat | 3 |
| #8 | Rotem Yehudar Rinat | 1 |
| #9 | Dan Phyllis | 1 |
| #10 | Tishler Hila | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2018025270A1 | Enriched modified vitamin d binding protein compositions and use thereof | |
| WO2016162867A1 | Combination therapy of macrophage activating factor and pd-1 signaling inhibitors | |
| US2018078613A1 | Macrophage activating factor for treating benign or precancerous papillomas | |
| AU2014279627A1 | Compositions comprising Gc- macrophage activating factor and uses thereof | |
| CN103547280A | Macrophage activating factor for pharmaceutical compositions |